__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________...Show more

UK| July 2021 | 129283

__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________...Show more

UK | March 2021 | 107321

__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________...Show more

MUL20-E055 November 2020.
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]